Ventuno Biotech
French tech company | Builders Republic
About
Early-stage biotech developing next-generation antibody immunotherapies for hard-to-treat cancers — designing antibodies that mobilize the immune system to target and eliminate tumors that resist chemotherapy and radiotherapy, with research run at a Montpellier cancer-research institute.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2025
- City
- LYON
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 1
- Amount raised
- 3.0 M€ raised since 2020
Funding rounds
- Seed — 2025